When measures are adapted to T1D, i.e., validated in a population with T1D or adapted to consider both insulin misuse and the restricted diet in T1D, the differences between T1D patients and controls are significantly lower than when generic measures are used. The gene discussed is INS; the disease is type 1 diabetes mellitus.